These results were further supported by in vivo studies where the NPs formulation achieved reduced tumor growth compared to the free DOX, accompanied with reduced KI-67 and enhanced TUNEL-positive levels in drug-resistant xenografted BALB/c nude mice [65]. This evidence concerns the gene MKI67 and neoplasm.